China Medical System Holdings Limited 0867.HK Stock
China Medical System Holdings Limited Price Chart
China Medical System Holdings Limited 0867.HK Financial and Trading Overview
| China Medical System Holdings Limited stock price | 7.11 HKD |
| Previous Close | 12.64 HKD |
| Open | 12.78 HKD |
| Bid | 13.02 HKD x 0 |
| Ask | 13.06 HKD x 0 |
| Day's Range | 12.6 - 13.12 HKD |
| 52 Week Range | 8.54 - 14.86 HKD |
| Volume | 1.47M HKD |
| Avg. Volume | 3.39M HKD |
| Market Cap | 31.92B HKD |
| Beta (5Y Monthly) | 0.889272 |
| PE Ratio (TTM) | 8.857143 |
| EPS (TTM) | 1.06 HKD |
| Forward Dividend & Yield | 0.55 (4.45%) |
| Ex-Dividend Date | May 3, 2023 |
| 1y Target Est | 16.87 HKD |
0867.HK Valuation Measures
| Enterprise Value | 26.19B HKD |
| Trailing P/E | 8.857143 |
| Forward P/E | 8.292994 |
| PEG Ratio (5 yr expected) | 1.59 |
| Price/Sales (ttm) | 3.488929 |
| Price/Book (mrq) | 2.1882355 |
| Enterprise Value/Revenue | 2.863 |
| Enterprise Value/EBITDA | 6.964 |
Trading Information
China Medical System Holdings Limited Stock Price History
| Beta (5Y Monthly) | 0.889272 |
| 52-Week Change | 10.10% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 14.86 HKD |
| 52 Week Low | 8.54 HKD |
| 50-Day Moving Average | 12.63 HKD |
| 200-Day Moving Average | 11.81 HKD |
0867.HK Share Statistics
| Avg. Volume (3 month) | 3.39M HKD |
| Avg. Daily Volume (10-Days) | 3.7M HKD |
| Shares Outstanding | 2.45B |
| Float | 1.24B |
| Short Ratio | N/A |
| % Held by Insiders | 49.55% |
| % Held by Institutions | 19.40% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0.534 |
| Trailing Annual Dividend Yield | 4.22% |
| 5 Year Average Dividend Yield | 417.00% |
| Payout Ratio | 0.4012 |
| Last Split Factor | 3:2 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 35.61% |
| Operating Margin (ttm) | 38.82% |
| Gross Margin | 76.89% |
| EBITDA Margin | 41.10% |
Management Effectiveness
| Return on Assets (ttm) | 13.23% |
| Return on Equity (ttm) | 23.75% |
Income Statement
| Revenue (ttm) | 9.15B HKD |
| Revenue Per Share (ttm) | 3.73 HKD |
| Quarterly Revenue Growth (yoy) | 4.59% |
| Gross Profit (ttm) | 7.04B HKD |
| EBITDA | 3.76B HKD |
| Net Income Avi to Common (ttm) | 3.26B HKD |
| Diluted EPS (ttm) | 1.47 |
| Quarterly Earnings Growth (yoy) | 5.09% |
Balance Sheet
| Total Cash (mrq) | 5.88B HKD |
| Total Cash Per Share (mrq) | 2.4 HKD |
| Total Debt (mrq) | 1.81B HKD |
| Total Debt/Equity (mrq) | 12.3 HKD |
| Current Ratio (mrq) | 3.069 |
| Book Value Per Share (mrq) | 5.95 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 3.55B HKD |
| Levered Free Cash Flow (ttm) | 2.09B HKD |
Profile of China Medical System Holdings Limited
| Country | Hong Kong |
| State | N/A |
| City | North Point |
| Address | Island Place Tower |
| ZIP | N/A |
| Phone | 852 2369 7678 |
| Website | https://www.cms.net.cn |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 5647 |
China Medical System Holdings Limited, an investment holding company, manufactures, sells, markets, and promotes pharmaceutical products in the People's Republic of China. The company's products include Plendil for the treatment of hypertension and stable angina pectoris; XinHuoSu for the treatment of acute heart failure; Deanxit for the treating mild-to-moderate depression, anxiety, and psychosomatic affections; Ursofalk for the treatment of cholesterol gallstones in the gallbladder, cholestatic liver disease, and biliary reflux gastritis; Salofalk for treating Ulcerative Colitis and Crohn's disease; Bioflor for the treatment of diarrhea; Combizym for dyspepsia; Augentropfen Stulln Mono eye drops to treat senile macula degeneration and asthenopia; and Hirudoid for blunt traumata with or without hematomas and superficial phlebitis insofar. It also offers DanShenTong capsules for treating acne, tonsillitis, otitis externa, boils, carbuncle, traumatic infection, burn infection, mastitis, cellulitis, osteomyelitis, etc.; XiDaKang, a protein hydrolysate oral solution; YiNuoShu for treating respiratory diseases; Ganfule capsules for the treatment of primary cancer of the liver; Imdur for the treatment of coronary heart disease, chronic heart failure, and myocardial infarction, as well as for prevention of vasospasm and mixed angina; and Parlodel tablets for the endocrine and neuro system indications. In addition, the company provides Elcatonin injection for osteoporosis; YinlianQinggan granules for treating acute hepatitis A and chronic hepatitis B; Lamisil tablets for treating fungal infections on skin and hair; and MOVICOL for treating chronic constipation and faecal impaction. In addition, it is involved in the agriculture and livestock activities. The company was founded in 1995 and is headquartered in North Point, Hong Kong. China Medical System Holdings Limited is a subsidiary of Treasure Sea Limited.
Q&A For China Medical System Holdings Limited Stock
What is a current 0867.HK stock price?
China Medical System Holdings Limited 0867.HK stock price today per share is 7.11 HKD.
How to purchase China Medical System Holdings Limited stock?
You can buy 0867.HK shares on the HKSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for China Medical System Holdings Limited?
The stock symbol or ticker of China Medical System Holdings Limited is 0867.HK.
Which industry does the China Medical System Holdings Limited company belong to?
The China Medical System Holdings Limited industry is Drug Manufacturers-Specialty & Generic.
How many shares does China Medical System Holdings Limited have in circulation?
The max supply of China Medical System Holdings Limited shares is 2.44B.
What is China Medical System Holdings Limited Price to Earnings Ratio (PE Ratio)?
China Medical System Holdings Limited PE Ratio is 6.70754770 now.
What was China Medical System Holdings Limited earnings per share over the trailing 12 months (TTM)?
China Medical System Holdings Limited EPS is 1.06 HKD over the trailing 12 months.
Which sector does the China Medical System Holdings Limited company belong to?
The China Medical System Holdings Limited sector is Healthcare.